Probing the role of the conserved residue Glu166 in a class A β-lactamase using neutron and X-ray protein crystallography.
Patricia S LanganBrendan SullivanKevin L WeissLeighton CoatesPublished in: Acta crystallographica. Section D, Structural biology (2020)
The amino-acid sequence of the Toho-1 β-lactamase contains several conserved residues in the active site, including Ser70, Lys73, Ser130 and Glu166, some of which coordinate a catalytic water molecule. This catalytic water molecule is essential in the acylation and deacylation parts of the reaction mechanism through which Toho-1 inactivates specific antibiotics and provides resistance to its expressing bacterial strains. To investigate the function of Glu166 in the acylation part of the catalytic mechanism, neutron and X-ray crystallographic studies were performed on a Glu166Gln mutant. The structure of this class A β-lactamase mutant provides several insights into its previously reported reduced drug-binding kinetic rates. A joint refinement of both X-ray and neutron diffraction data was used to study the effects of the Glu166Gln mutation on the active site of Toho-1. This structure reveals that while the Glu166Gln mutation has a somewhat limited impact on the positions of the conserved amino acids within the active site, it displaces the catalytic water molecule from the active site. These subtle changes offer a structural explanation for the previously observed decreases in the binding of non-β-lactam inhibitors such as the recently developed diazobicyclooctane inhibitor avibactam.
Keyphrases
- amino acid
- escherichia coli
- gram negative
- klebsiella pneumoniae
- high resolution
- transcription factor
- multidrug resistant
- crystal structure
- dual energy
- electron microscopy
- binding protein
- magnetic resonance imaging
- dna binding
- emergency department
- wild type
- computed tomography
- molecular dynamics simulations
- machine learning
- deep learning
- drug induced
- small molecule